Background: Complex cardiac rhythm management device (CRMD) therapy provides an important treatment option for people at risk of sudden cardiac death. Despite the survival benefit, device implantation is associated with significant physical and psychosocial concerns presenting considerable challenges for the decision-making process surrounding CRMD implantation for patients and physicians. Aims: The purpose of this scoping review was to explore what is known about how adult (>16 years) patients make decisions regarding implantation of CRMD therapy. Methods: Published, peer reviewed, English language studies from 2000 to 2016 were identified in a search across eight healthcare databases. Eligible studies were concerned with patient decision-making for first time device implantation. Quality assessment was completed using the mixed methods appraisal tool for all studies meeting the inclusion criteria. Results: The findings of eight qualitative and seven quantitative studies, including patients who accepted or declined primary or secondary sudden cardiac death prevention devices, were clustered into two themes: knowledge acquisition and the process of decision-making, exposing similarities and distinctions with the treatment decision-making literature.
Introduction
Sudden cardiac death (SCD) is a global problem. The exact incidence of SCD in Europe and the USA remains unclear although it is responsible for an estimated 15-20% of all deaths. 1 It is usually the result of ventricular arrhythmia, most often associated with underlying heart disease or inherited conditions. 2 Meta-analysis of large randomised controlled trials has firmly established the survival benefit of complex cardiac rhythm management devices (CRMDs) such as implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy (CRT) over conventional drug therapy, in a targeted but growing population of people who have survived (secondary device), or are at substantial risk (primary prevention) of sudden cardiac arrest (SCA). [3] [4] [5] [6] Despite the evident survival benefit, CRMD implantation is associated with significant potential complications and substantial patient and partner physical and psychosocial concerns. 7 The enormity and uncertainty of both benefits and harms present challenges for the decision-making process surrounding CRMD implantation for patients and healthcare professionals. The degree of satisfaction with the decision to accept or decline CRMD implantation is complex, may affect the quality of the immediate treatment phase and influence the individuals' overall acceptance, psychosocial adjustment and longterm outcomes with or without the device. 7 A wealth of existing knowledge related to patient treatment decision-making, in the context of life-threatening conditions and the presence of uncertainty, complexity and limited rationality, refers predominantly to cancer with less emphasis on cardiovascular disease. The literature describes the distinction and interplay between individual and collective, participatory aspects of treatment decision-making. 8 Individual decision-making refers to systematic and nonsystematic (heuristic) methods of gathering information. [9] [10] [11] [12] Participatory decision-making has been conceptualised according to several models revolving around the level of control an individual has over decision-making, ranging from 'passive' paternalistic physician control, to 'active' informed patient control or shared involvement in information exchange, deliberation and final choice between physician, patient and significant others. [13] [14] [15] Shared decision-making is widely advocated as the gold standard in the literature, [15] [16] [17] [18] yet while most patients appear to prefer a joint approach, 19 a significant minority favour a passive style and others a more active approach. [20] [21] [22] [23] [24] Factors such as patient demographics, condition, severity and healthcare experience appear to influence preference for involvement. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] A connection between achieving the desired level of involvement, being informed and decisional satisfaction has been reported, 22, [31] [32] [33] [34] yet discordance between desired and actual decisional control appears to be prevalent. 21, 24, 32, [35] [36] [37] [38] Regardless of the level of participation, widespread misunderstanding and dissatisfaction with the amount of information received appears to be common. 22, 23, 26, 39, 40 Given the context of serious, sudden lifethreatening cardiac arrhythmia and the uniqueness of device therapy it is not known whether findings from the broader literature can be applied to patients making decisions regarding CRMD implantation. In view of this, a scoping review was undertaken to discover 'what is known about how adult (>16 years) patients make decisions regarding implantation of complex cardiac rhythm management device (CRMD) therapy'.
Methods
A five-stage scoping framework 41 was used to explore the extent, range and nature of available knowledge, identify gaps in the existing literature, establish key areas for further study and consider implications for practice. The scoping framework involved developing the research question, identifying relevant studies, study selection, charting the data and reporting the results. The framework was further refined to include an analysis of quality [42] [43] [44] [45] .
The eligibility criteria (Table 1) were deliberately broad and not restricted by study design. Exclusion parameters were developed iteratively in response to exposure to the literature, to ensure that patient decision-making related to CRMDs remained the focal point of the review. The search strategy was designed to locate good quality, relevant studies published in English from the year 2000, reflecting the fact that complex CRMDs were not in mainstream practice until the 1990s. Search terms such as: adult patient and cardiac arrest or disease or failure or myopathy, and implantable defibrillator or device therapy and decision-making; were applied across eight databases (Table 2 ) particular to medicine, psychology, nursing, allied health publications and four grey literature databases. Hand searching of cardiology and decision-making journals and citation tracking ensured inclusivity. Titles and abstracts were searched (AM-K) for relevance against eligibility criteria retaining 244 (Table 1) . Following the removal of duplications, 173 citations were organised into: include (n=35), unsure (n=8) and exclude (n=130) groups and full text scrutinised. Alternative publications of the same dataset were pooled and papers that did not meet the inclusion criteria or provide sufficient detail for analysis were excluded, resulting in 15 studies. Independent review (PM) of a random sample of 30 citations confirmed eligibility (Figure 1 ). The mixed methods appraisal tool (MMAT) 46 was used to Table 1 . Inclusion criteria applied to scoping review on cardiac patient decision-making.
Included decision-making related to: i.
Patients with serious life-threatening cardiac illness who meet selection criteria for ICD for secondary or primary prophylactic prevention of life-threatening ventricular arrhythmia or CRT for heart failure and at risk of life-threatening arrhythmia ii.
Age >16 years to include adolescents iii.
First time implant iv.
Decision theory development or validation related to cardiac device therapy v.
Individual and/or collective decision-making related to cardiac device therapy vi.
Influential factors affecting acceptance or refusal of cardiac device therapy vii.
Interventions e.g. decision aids to support decision-making related to cardiac device therapy viii.
Development and validation of decision-making outcome measures related to cardiac device therapy ix.
Any study design and applicable non-research material e.g. policy and guidance patient decision-making Adapted from Moher et al. 116 appraise methodological quality. This tool allows assessment of quantitative, qualitative and mixed methods designs, has good reported validity and reliability [46] [47] [48] and has been used in previous reviews. 49, 50 Research design, methods and key findings extracted from the primary studies were collated into a detailed data chart to enable identification, interpretation and synthesis of commonalities, themes and gaps in the literature. 41, 45 Results
Overview of methodological approaches
Of the 3451 citations retrieved, 15 studies fulfilled the inclusion criteria. 49 which included an independent, comparative MMAT assessment. Of 13 appraised studies, six scored 100%, four scored 75% and three scored 50% (Table 3) .
Qualitative thematic analysis
The selected papers were organised into 'clusters' based on study aims and within each cluster 'subthemes' emerged from the study findings (Table 4) . There appeared to be a focus on the 'benefit bias' presented in published guidelines. Some recipients reported a tendency for physicians to focus on the medical procedure, with knowledge of risk only becoming apparent when experienced post-implant. 51, 56, 61 Unexplained medical jargon was often used and there was a primary emphasis on prevention of SCD whereas study data on the prevalence of actual life-saving shock therapy, the number who require shock therapy or the risk of death despite shock therapy was rarely included. 51, 56 Some recipients reported receiving advice about potential periprocedural risks, e.g. infection, bleeding, but denied discussion of post-implant complications such as lead displacement, ICD recall or inappropriate shock. 51, 52, 54, 56, 61 Patients reported infrequent reference to possible psychosocial outcomes, e.g. anxiety, depression or quality of life issues other than social concerns such as security devices. 56 An emphasis on ICD as the only option, with minimal recall of any discussion of alternatives, e.g. drug or ablation therapy existed. 51, 58 The use of decision aids did not feature in the ICD studies with the exception of Hazleton et al. 57 who designed and tested the ICD decision analysis scale (DAS) and recommended its use in practice to facilitate information exchange and deeper discussion of patient knowledge, understanding and preferences for an ICD. 10 Non Randomised Descriptive Perceived consequence of heart failure said to be stroke (42%), SCD (28%), MI (17%), don't know (14%).
68% believed medication could prevent SCD, 16% believed exercise and diet could prevent SCD. Only 8% understood SCD preventative role.
When asked about ICD function 52% correctly answered SCD prevention, 48% were not aware of SCD preventative role.
Most feared consequence of heart failure was being bed bound (37%), breathlessness (30%), SCD (17%), chest pain (8%), don't know (8%) All believed ICD would restrict life style including inability to do heavy lifting (30%), problems with electrical devices (17%), flying (10%), swimming (12%), sexual activity (5%)
Chan conclude that limited consultation time, language barriers, deep seated beliefs that contradict physician advise could explain lack of understanding Non Randomised Descriptive Prospective study to develop and test a measure (ICD-DAS) of patient evaluated ICD pros and cons and its impact upon patient decision-making for a primary ICD or CRT (precise indication and device type unclear). Two-factor measure for ICD decision-making established with two subscales: ICD Pros and ICD Cons.
ICD -DAS provides empirically tested & clinically useful pros & cons scale to help patient decisionmaking.
(Continued) 13 Integrative Review Pt's with ICD misunderstood functionality or over estimated benefit. Recommend clinicians better support patients by 1) verifying understanding; 2) eliciting preferences; 3) promoting shared decisionmaking 53 reported that 235 (98%) relied solely on expert opinion for information, whereas two studies 52, 63 revealed an almost 50:50 split between passive and active decision-makers. Participants who adopted an active approach appeared to invest time to systematically seek further information and second opinions from a range of sources, take time to comprehend fully the function of and develop trust in the device to reach a decision. 52, 55, 58, 63, 64 Rather than distinct approaches, Carroll et al. 58 described participants as occupying a position along a continuum between 'passive, indifferent' and 'active, engaged' decision-making. For some patients information transfer appeared to be the crucial element of, and synonymous with, involvement in decision-making rather than implementation of the final decision. 58 Others made 'independent decisions' based on their preferences while acknowledging guidance by physician recommendation or the experience of others as a potential influence. 58, 61, 64 Subtheme 2.2: Factors influencing the decision style. Fluctuation in the level of engagement in decision-making appeared to be influenced by:
Age: older adults contemplating device therapy were more inclined to passivity deferring the decision to physician or family members 54, 56 (small sample sizes limit generalisability).
Gender: despite little mention of potential gender differences, one study found that women were 2.7 times more likely than men to actively confirm their ICD decision to others and consider the physician to be a detailed information giver rather than authority figure. 55, 66 Passivity was influenced by the degree of importance assigned to various situational factors:
• • Perceived difficulty of the decision, fear and uncertainty; 51,52,54-56,58,61,63 • • Symptom severity and current health state; 51, 54, 55, 58, 59, 61, 63 • • Insufficient perception of severity, symptomatology and minimised belief in personal risk and device necessity among some patients contemplating primary devices, 58, 59 (appreciation of personal risk prompted active involvement for others); 58 • • Confidence and trust in physician recommendation; 51, 52, 54, 55, 58, 63 • • Lack of trust in the physician prompted passive reliance upon well informed family to support or make the decision; 55, 58, 59 • • Social and family influence; 55, 58, 63 • • Insufficient time to deliberate; 51, 53, 55, 56, 58, 63 • • Pervading sense of 'no choice' and an 'offer you can't refuse', among some secondary ICD recipients who described themselves as laymen unable to have an opinion on such complex medical decisions. 51, 54, 55 Groarke et al. 52 explored desired and actual participation and found that 40 (53%) patients desired passive involvement with 35 (47%) reporting that the decision had been made by the physician. Thirty-five (47%) preferred an active role but only 19 (25%) reported making independent choices. 52 Despite an apparent mismatch between desired and actual involvement, 70 (93%) respondents were satisfied with their decision. 52 
Discussion
The widespread lack of knowledge and understanding of condition, device role, risks and alternative options across the CRMD studies is a concern. Reported inaccuracies may have been a function of the time between implant and data collection (1-16 years) on retention and recall of information. However, interviews one month post-implant by Carroll et al. 58 revealed similar findings, suggesting that the gravity of the situation may have affected what recipients hear, recall and a focus on survival information. Age, cognitive and emotional barriers, communication deficits, situation seriousness, individual experience and variation in the desired amount and type of device information may impact on patient perception of information or even reduce the relevance of some facts. 56, 67 The ICD studies reviewed referred predominantly to patient-physician information exchange, whereas many implant centres now adopt a multiprofessional approach. The focus on benefit bias and procedural issues, rather than psychosocial outcomes, resembles other studies which reveal differences in physician priority on survival and longevity over patients' preference for preservation of quality of life. 68 In a multicentre Danish survey, physicians reported greater emphasis on the clinical aspects and procedural risks of ICD implantation and focus on advantages at the expense of disadvantages of treatment, than non-physicians. 69 This was reflected in a recent systematic review that concluded that most patients, regardless of intervention type, overestimated benefit and underestimated harm. 70 Thus there is a need for comprehensible, predictive information regarding benefits and risks to augment realistic expectations and informed choices. 70, 71 However, physician recommendations are made on increasingly complex clinical evidence, which is indication and device specific and reliant on contemporary expert knowledge which may influence the degree of importance assigned to clinical matters. It may also challenge the ability of the physician to gauge accurately what, and how much, information a patient wants and how to present it in a clear, understandable way, relevant to the patient's clinical need and capacity to assimilate and comprehend it. Furthermore, physicians spend significantly less time with ICD recipients prior to implantation than non-physicians, limiting the opportunity to consider the emotional impact. 69 In contrast, non-physicians reported a greater emphasis on psychosocial and quality of life concerns. 69 Thus, increased involvement of cardiac specialist nurses, clinical physiologists and psychologists, and the development of more reliable patient websites to reinforce and complement physician information may improve this. 72 The decision approach may influence information exchange. While shared decision-making and collaborative styles are key topics in the decision-making literature, [73] [74] [75] [76] [77] [78] [79] [80] the level of shared decision-making in cardiology consultations is not well known, 81 and only one CRMD study alluded to patient perception of joint decision-making. 52 In contrast to the preference for shared decisionmaking in the general literature, 24, 38, 76 reference to distinct passive and active approaches dominated the CRMD studies. The majority of ICD patients desired passive involvement, echoing findings among general cardiology patients. 36 Rapid, intuitive referral to the 'expert opinion heuristic' and passive deferral of decision-making responsibility to the physician was evident among secondary device recipients. Although paternalistic and criticised for failing to embrace patient-centredness and informed choice, 14, 82, 83 this approach could be appropriate in the context of post-SCA secondary prevention in which the benefit-risk ratio is well established. 4 Recovery from the traumatic event, symptom severity and treatment complexity, limited time to deliberate, feeling ill-equipped to make a choice and high levels of trust in physician expertise, evident in the CRMD studies, are factors widely associated with passivity in the decision literature. 20, [84] [85] [86] [87] [88] However, passivity was also described among patients contemplating primary prophylactic devices 53, 58, 61, 63 when symptoms may be absent, suggesting that more deliberation time may not increase engagement in decision-making. The clarity of the perceived benefit and risk for primary devices may be a factor. The risk of life-threatening arrhythmia and survival benefit afforded by the device, in the presence of ischaemic aetiology or certain heart failure characteristics, is well known. 3, 5, 6 Therefore, reference to clinical guidelines for CRMD implantation, particularly when framed as essential rather than optional, 55, 59 may present an air of confidence which promotes patient trust in physician recommendation and consequent passive acceptance of device therapy. It may not however guarantee 'informed' consent. Furthermore, predictive risk stratification of inherited cardiac conditions is less established and the balance between not treating and risking a preventable arrhythmic event and the inevitable cost and complications associated with implantation is uncertain. 89 Therefore, a lack of standardised information may lead to poorer patient understanding and diminished confidence in the physician and perceived strength of recommendation, which may explain subsequent passive reliance on significant others to decide 55, 58, 59 or refusal of therapy. 58 Ultimately, an explicit link between passivity, poorer knowledge and understanding described by the CRMD studies is problematic. 51, 53, 54, 58 In contrast, independent information gathering and leaving the ultimate treatment decision exclusively to CRMD patients presupposes that they are truly autonomous, that their information needs, values and preferences are known, and they are certain of their wishes. 14 The source of the information is also a concern as the reliability and confidence in information acquired from 'non-expert' sources, such as family, friends and media avenues has been described as 'highly variable', 39, 90, 91 and may explain the lack of accurate knowledge also found among 'active information seeking' device recipients. 64 Moreover, the expression and interpretation of patient preferences and values, based on subconscious intuitive judgement processes, may challenge decision-making. For instance, referral to past experiences or anecdotal experiences of others, known as the 'availability heuristic', 9,11 thought to motivate some patients to accept or decline therapies, 15, 86 was acknowledged among CRMD patients. 53, 61, 64 This may be relevant as the exact mechanism of heuristic-based treatment decision-making is not clear in the general literature; however, the potential bias effect on rational decision-making has been demonstrated. 9, 19, 37, [92] [93] [94] Individuals could be induced to make suboptimal decisions based on positive or negative events that contradict physician advice. 53 For example, third-hand knowledge of shock experience or device-related complications may present sufficient anticipation of adverse events to deter some who would benefit from acceptance, presenting a negative availability heuristic. In contrast, risk aversion may exaggerate patient preference for more invasive treatments, whereby the presence of a small but above average risk of SCA may unnecessarily provoke patients to request the highest end technology available. The degree to which primary and secondary CRMD recipients refer to systematic information gathering and heuristic processes merits further investigation as the literature is not clear.
Collaborative decision-making acknowledges an inferred imbalance in medical knowledge and social power between patient and physician, by allowing each to lead different aspects of the discussion, capturing the notion of negotiated responsibility, mutual participation and cooperation rather than emphasis on shared choice. 13, [95] [96] [97] [98] The desire for information exchange and deliberation expressed by some CRMD patients, while relinquishing responsibility for the final decision to physician expertise 58 was an indicator of active involvement in collaborative decisionmaking and may paradoxically represent a degree of autonomy. 22, 97, 99, 100 Greater emphasis on collaborative CRMD decision-making may facilitate improved knowledge acquisition and foster the inclusion of personal preference, which is valued and perceived as greater involvement in decision-making by patients. 74, [101] [102] [103] Decision aids designed to support preference-sensitive decision-making improve understanding, enhance concordance between values and choice and reduce decisional conflict have become increasingly popular in the literature. 16, [104] [105] [106] [107] However, thus far they have not been fully implemented in general practice 103, 108 or in the context of CRMD uptake. The only CRMD study to develop and test a decision aid specific to ICD 57 was based on a relatively small sample of clinic patients and may not be entirely representative. A pilot study to develop and test a decision aid designed to support patients contemplating primary prophylaxis ICD implantation is currently underway. 109 Although decision approach did not appear to influence device acceptance, 58 inadequate knowledge was associated with device refusal 53, 62 and dissatisfaction. 54 Other factors influencing acceptance or refusal such as condition severity and perception of necessity, strength of, trust in and desire to heed the recommendation and the trade-off between longevity and quality of life, corresponds with cancer treatment decision-making. 86 An association between increasing age, passivity and poor knowledge acquisition described in the general decision literature 27, 29 was apparent among older adults contemplating device therapy; 54, 56 however, generalisation is limited by the small cohort size. Further focused investigation into the impact of complex factors associated with older age and potentially exacerbated in heart failure and post-SCA, such as diminished cognitive function, low health literacy, numeracy and depression 39, [110] [111] [112] [113] [114] [115] is warranted if support strategies to meet specific needs are to be developed. There was little mention of potential gender differences in the CRMD studies, 55, 66 although the tendency for women towards active engagement compares with other findings. 20, 23, 27, 97 Consistent with the treatment literature 86 there is limited information regarding the influence of culture, ethnicity and other potential demographic differences in the CRMD studies. The impact of device indication, type and role as an indicator of health status on decision-making is uncertain due to the inclusion of primary and secondary devices in several studies, therefore a more focused investigative approach on specific device types is recommended.
Limitations
Although the small number of studies included in the review could be considered a limitation, the reviewers were confident that a thorough and comprehensive search was undertaken. Unlike systematic reviews or narrative analysis of qualitative studies with similar methodological approaches, scoping reviews by their very nature incorporate a range of published materials, study designs and mixed methods, and so the presenting challenge of attempting to summarise, interpret and synthesise the complex and often large volume of diverse data cannot be underestimated. Furthermore, qualitative content analysis in this context assumes a degree of interpretation of findings emerging from several studies, which have already been subject to researcher analysis and interpretation. The potential loss of some important findings is therefore real.
Conclusion
This scoping review generated some insight into the way patients approach decision-making related to CRMD recommendation, identified similarities and distinctions with the treatment decision-making literature, and exposed a lack of clarity and research activity specific to some patients. It has demonstrated scope for an examination of relationships among a range of factors, with a particular focus on device indication and use of valid outcome measures within a more judicious timeframe. Further insight into what inspires active engagement, the degree and influence of heuristic thinking, time to deliberate and appropriateness of shared decision-making for patients contemplating CRMDs is recommended. Emphasis on the development of strategies to enhance information assimilation and recall is essential. Although decisional satisfaction and avoidance of cognitive dissonance and regret are evidence of effective patient decision-making, measures of decision outcome such as decisional control preference and concordance, conflict, satisfaction and regret are scarce in the literature and warrant greater inclusion. An appreciation of the way in which the patient arrives at a decision to proceed or not with CRMD implantation among different groups may provide a better understanding of potential disparities and the evidence to facilitate development of a framework of tailored information or decision aid, to enable effective collaborative decisionmaking, to facilitate truly informed choices, to improve the patient experience and to help acceptance and adjustment to life with technology. 
Implications for practice

